AT1 RECEPTOR

Oct 23, 11
Other articles:
  • Feb 17, 2011 – Blockade of the renin-angiotensin-aldosterone system (RAAS) is a key component of treatment of patients with systolic heart failure (HF) () .
  • Almost all AVP-neuron perikarya also expressed both the NK-3 receptor and AT- 1 receptor. Paper-8829784. The bb allele of the eNOS gene was found in 74% .
  • Candesartan (Atacand). Nov 2010. Candesartan (Atacand) is an angiotensin II receptor antagonist with an IC50 of 15 µg/kg. S2037 .
  • Jun 14, 2010 – Angiotensin-receptor blockers have been associated with a modest increased risk of developing cancer in a new meta-analysis. Specifically .
  • Angiotensin II receptor blockers (angiotensin II inhibitors) treat conditions such as high blood pressure.
  • File Format: PDF/Adobe Acrobat - Quick View
  • by Dr. Omudhome Ogbru
  • by C Sumners - Cited by 69 - Related articles
  • File Format: PDF/Adobe Acrobat - Quick View
  • Jun 14, 2010 – Study: Common Blood Pressure Meds Show Slight Increase in Lung, Prostate, and Breast Cancer Risk.
  • Novel paramagnetic selective angiotensin AT1 receptor antagonists (sartans) bearing nitroxides (3, 4) have been prepared and their pharmacology evaluated in .
  • Jun 3, 2011 – A type of blood pressure-lowering medication known as angiotensin receptor blockers won't increase a patient's risk for cancer, the Food and .
  • Mar 23, 1999 – Mechanism of action: The final active messenger of the renin-angiotensin pathway is angiotensin II. Angiotensin II binds to AT1 receptors to .
  • by AJJ Wood - 1996 - Cited by 10 - Related articles
  • by L Oliveira - 2007 - Cited by 25 - Related articles
  • Heran BS, Wong MMY, Heran IK, Wright JM. Blood pressure lowering efficacy of angiotensin receptor blockers for primary hypertension. Cochrane Database of .
  • Angiotensin II receptor, type 1 or AT1 receptor is an angiotensin receptor .
  • Read about angiotensin receptor blockers (ARBs) a class of drugs used to treat conditions such as high blood pressure, congestive heart failure, stroke risk, and .
  • 2008-04-01, Updated, RELATION, is a GO:0031701 (angiotensin receptor binding) . 2007-08-09, Added, SYNONYM, type 1 angiotensin receptor ligand .
  • Angiotensin receptor antagonists are a new class of antihypertensive drugs. They act by blocking the angiotensin (AT1 type) receptor, which controls the .
  • Angiotensin II receptor antagonists, also known as angiotensin receptor .
  • Angiotensin receptor blockers (ARBs). Current ARBs block only the AT1 receptor. This effect, if unopposed, could lead to an increased circulating level of .
  • The AT1 receptor is coupled to a Gq/11 protein that activates phospholipase C ( PLC) and leads to production of inositol 1,4,5-trisphosphate (InsP3) and .
  • File Format: PDF/Adobe Acrobat
  • Angiotensin Receptor Blockers (ARBs): Drug Safety Communication - Drug Safety Review Completed. June 2, 2011. Audience: Cardiology, Oncology, Family .
  • Angiotensin Receptor Blockers (ARBs). General Pharmacology. These drugs have very similar effects to angiotensin converting enzyme (ACE) inhibitors and .
  • Apr 15, 2011 – A nationwide cohort study of Danish registry data, published in the renowned journal Circulation, refutes a previously suggested link between .
  • by R Jagannathan - 2010 - Cited by 1 - Related articles
  • Your browser may not have a PDF reader available. Google recommends visiting our text version of this document.
  • by CH Chang - 2011 - Related articles
  • by C Schindler - 2008 - Cited by 2 - Related articles
  • Find out more about ACE inhibitors and angiotensin II receptor blockers with Bupa online. Click here for a selection of information on ACE inhibitors and .
  • by JP Habashi - 2011 - Cited by 7 - Related articles
  • Jun 2, 2011 – The U.S. Food and Drug Administration today announced that a group of medications used to control high blood pressure, called angiotensin .
  • Angiotensin receptor blockers are a medication often used to treat high blood pressure. UK blood pressure charity information about angiotensin receptor .
  • by S Wassmann - 2004 - Cited by 8 - Related articles
  • by I Sipahi - 2010 - Cited by 104 - Related articles
  • Your browser may not have a PDF reader available. Google recommends visiting our text version of this document.
  • Jun 3, 2011 – Angiotensin receptor blockers (ARBs) do not increase cancer risk, the FDA reported, after investigating the blood pressure medications .
  • Why you take this medication: These medications are often used as alternatives in patients who re intolerant to ACE inhibitors. Also used in conjunction with .
  • by S AbdAlla - 2000 - Cited by 305 - Related articles
  • Angiotensin-II receptor antagonists (or blockers) are a newer class of antihypertensive agents. These drugs are selective for angiotensin II (type 1 receptor); .
  • The angiotensin receptors are a class of G protein-coupled receptors with angiotensin II as their ligands. They are important in the renin-angiotensin system : .
  • Jun 14, 2010 – Some widely used blood pressure drugs called angiotensin-receptor blockers may be associated with an increased risk of cancer, researchers .
  • Oct 11, 2011 – Learn about angiotensin II receptor blockers (ARBs) for the treatment of hypertension.
  • Angiotensin II receptor blockers (ARBs) are a new class of antihypertensive medications. Also known as angiotensin II receptor antagonists, these medications .
  • Polyclonal Antibody against Angiotensin Receptor 1 for use in ELISA.
  • by G Wallukat - 1999 - Cited by 303 - Related articles
  • Aug 19, 2010 – This 3D animation shows where the At1 receptor is expressed and how it is activated by angiotensin II via the RAS cascade.
  • by NC Li - 2010 - Cited by 51 - Related articles

  • Sitemap